{"title":"FOXP1 phosphorylation antagonizes its O-GlcNAcylation in regulating ATR activation in response to replication stress.","authors":"Xuefei Zhu, Congwen Gao, Bin Peng, Jingwei Xue, Donghui Xia, Liu Yang, Jiexiang Zhang, Xinrui Gao, Yilin Hu, Shixian Lin, Peng Gong, Xingzhi Xu","doi":"10.1038/s44318-024-00323-x","DOIUrl":null,"url":null,"abstract":"<p><p>ATR signaling is essential in sensing and responding to the replication stress; as such, any defects can impair cellular function and survival. ATR itself is activated via tightly regulated mechanisms. Here, we identify FOXP1, a forkhead-box-containing transcription factor, as a regulator coordinating ATR activation. We show that, unlike its role as a transcription factor, FOXP1 functions as a scaffold and directly binds to RPA-ssDNA and ATR-ATRIP complexes, facilitating the recruitment and activation of ATR. This process is regulated by FOXP1 O-GlcNAcylation, which represses its interaction with ATR, while CHK1-mediated phosphorylation of FOXP1 inhibits its O-GlcNAcylation upon replication stress. Supporting the physiological relevance of this loop, we find pathogenic FOXP1 mutants identified in various tumor tissues with compromised ATR activation and stalled replication fork stability. We thus conclude that FOXP1 may serve as a potential chemotherapeutic target in related tumors.</p>","PeriodicalId":50533,"journal":{"name":"EMBO Journal","volume":" ","pages":"457-483"},"PeriodicalIF":9.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11729909/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMBO Journal","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1038/s44318-024-00323-x","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
ATR signaling is essential in sensing and responding to the replication stress; as such, any defects can impair cellular function and survival. ATR itself is activated via tightly regulated mechanisms. Here, we identify FOXP1, a forkhead-box-containing transcription factor, as a regulator coordinating ATR activation. We show that, unlike its role as a transcription factor, FOXP1 functions as a scaffold and directly binds to RPA-ssDNA and ATR-ATRIP complexes, facilitating the recruitment and activation of ATR. This process is regulated by FOXP1 O-GlcNAcylation, which represses its interaction with ATR, while CHK1-mediated phosphorylation of FOXP1 inhibits its O-GlcNAcylation upon replication stress. Supporting the physiological relevance of this loop, we find pathogenic FOXP1 mutants identified in various tumor tissues with compromised ATR activation and stalled replication fork stability. We thus conclude that FOXP1 may serve as a potential chemotherapeutic target in related tumors.
ATR信号在感知和响应复制应激中是必不可少的;因此,任何缺陷都会损害细胞功能和存活。ATR本身是通过严格调控的机制激活的。在这里,我们确定FOXP1,一个包含叉头盒的转录因子,作为协调ATR激活的调节因子。我们发现,与转录因子的作用不同,FOXP1的功能是作为一个支架,直接结合到RPA-ssDNA和ATR- atrip复合物上,促进ATR的募集和激活。该过程受FOXP1 o - glcnac酰化调控,FOXP1 o - glcnac酰化抑制其与ATR的相互作用,而chk1介导的FOXP1磷酸化在复制胁迫下抑制其o - glcnac酰化。为了支持这一环的生理相关性,我们在各种肿瘤组织中发现了致病的FOXP1突变体,这些突变体具有ATR激活受损和复制叉稳定性停滞。因此,我们得出结论,FOXP1可能作为相关肿瘤的潜在化疗靶点。
Shengqin Liu, Stephen O Opiyo, Karoline Manthey, Jason G Glanzer, Amanda K Ashley, Courtney Amerin, Kyle Troksa, Meena Shrivastav, Jac A Nickoloff, Greg G Oakley
期刊介绍:
The EMBO Journal has stood as EMBO's flagship publication since its inception in 1982. Renowned for its international reputation in quality and originality, the journal spans all facets of molecular biology. It serves as a platform for papers elucidating original research of broad general interest in molecular and cell biology, with a distinct focus on molecular mechanisms and physiological relevance.
With a commitment to promoting articles reporting novel findings of broad biological significance, The EMBO Journal stands as a key contributor to advancing the field of molecular biology.